首页> 外国专利> Seven Member Ring of Nucleosides as inhibitors of viral Replication, Methods for their Synthesis, Pharmaceutical compositions containing them and their use in the treatment of infections with viruses of the Flaviviridae Family

Seven Member Ring of Nucleosides as inhibitors of viral Replication, Methods for their Synthesis, Pharmaceutical compositions containing them and their use in the treatment of infections with viruses of the Flaviviridae Family

机译:七种核苷环作为病毒复制的抑制剂,其合成方法,含有它们的药物组合物及其在治疗黄病毒科病毒感染中的用途

摘要

Nucleoside analog compounds that inhibit replication of RNA-dependent viral RNA, compositions comprising these compounds and the use of these compounds for the treatment of viral infection, especially hepatitis C, in an infected host. Claim 1: A compound of the general structural formula (1) wherein X is O, S, SO2, N-R, CH-R, or C-RR; R is H; C1-4 alkyl, C2-4 alkenyl, or C2-4 alkynyl, each of which could be optionally substituted; CN, N3, halo, OH, CONH2, NH2, or amidino; R1 is OH, monophosphate, diphosphate, triphosphate, phosphonate, phosphoryl, a derivative of phosphonate, acyl, hydrogen, alkyl, O-acyl, O-alkyl, O-aryl,O-alcoxialquilo O-ariloxialquilo O- alquilo substituido O-alquenilo substituido O-alquinilo substituido alquilsulfonilo arilsulfonilo alquenilsulfonilo aralquilsulfonilo un residuo amino cido o cualquier substituto divisible que proporcione OH in vivo R2 R3 R4 y R5 cada uno independientemente es H OH SH NH2 halo alquilcarbonilo 1. Halohydrazide, haloalkyl, cyclopentadiene, o-asphalt, o-alkylsulfonyl; o-tar; o-aculo; s-tar; s-alquenilo; s-acilo; NH tar; n (TAR) 2; NH (alquenilo);N (alquenilo) 2; NH (TAR);N (asphalt) 2; NH (ACIO);N (acyl) 2; CONH2; COOH; CONH-alkyl; CON (alkyl) 2; COSH2; COSH-alkyl; COS (alkyl) 2; C1-6-O-C1-6 alkyl; C1-6-O-alkenyl alkyl; C1-6-O-alkynyl alkyl; C1-6-S-alkyl; C1-6-S-alkenyl alkyl; C1-6-S-alkynyl alkyl; CH2CN; or CH2N3; and each of R1 ',R2',R3',R4',R5 'and W independently is H, OH, C1-10 alkylcarbonyl, phosphoryl, phosphonate, phosphinate, phosphonoamidate, Cl, F, Br, I, CN, NO2, N3, NH2, acylamino, amide, amidine, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbonyl, thiocarbonyl, acyl, haloalkyl, haloalkenyl, haloalkynyl, cyclopropyl, sulfonyl, sulfoxide, sulfate, sulphonate, sulfamoyl, sulfonamide, C1-6-O-C1-6 alkyl, C1 alkyl -6-O-alkenyl, C1-6-O-alkynyl alkyl, C1-6-S-alkyl, C1-6-S-alkenyl alkyl, C1-6-S-alkynyl alkyl, CONH2, COOR, CH2CN, or CH2N3; and each R2, R3, R4 and R5 and their corresponding R 'can form a half spiro; each R2 + R3, R3 + R4,Or R4 + R5 can be combined into a ring composed of 3-6 members, among which 1-3 non atoms can be selected; each R2 '+ R3',R3'+R4',O R4 '+ R5' can be independently combined into a ring composed of 3-6 members, and the ring can optionally be composed of 1-3 heteroatoms; it is expected that at least two R2, R3, R4, R5 and W should be oh; it is further predicted that w will be oh only when x is ch-r or c-r-r; and any additional preview of R1, R2 and R3, R4 or R5 is Oh or NH2 followed by R1R2',R3',The corresponding r4'o R5 'cannot be Oh or NH2 at the same time; the reference is selected from the group (2),characterized in that, each occurrence of A, L and T independently is CH, N, C-alkyl, O or S depending on the correct valence; or C-halo, C-C1-6 alkyl, C-C2-6 alkenyl, C-C2-6 alkynyl, C2-6 alkylamino, C-CF3, C-OH, C-NH2, C-NO2, C-CN , C-N3, C-COOR, or C-CONH2; D is CH, C-CN, C-NO2, N, C-C1-6 alkyl, C-CONH2, C-CONH-C1-6 alkyl, C-CON (C1-6 alkyl) (C1-6 alkyl),C-NH2, C-alkoxy, C-OH, C-alkylamino, CC (= NH) NH2, C-COOH, C-COO-alkyl, C-CSNH2, C-CSNH-alkyl, C-CSN (alkyl) 2 , C- di (C1-6 alkyl) amino, C-halo, C-heterocycle, wherein any alkyl is optionally substituted by one to three substitutes selected from the group consisting of alkoxy, hydroxyl, carboxy, halo and amino, and in where the heterocycle is a 5- to 6- membered ring that has one to three heteroatoms; E is N or C-halo, C-C1-6 alkyl, C-C2-6 alkenyl, C-C2-6 alkynyl, C1-6 alkylamino, C-CF3, C-OH, C-NH2, C-NO2, C-CN, C-N3, C-COOR, or C-CONH2; Z is O or S; R6, R7, R8 and R9, each independently is H, OH, SH, NH2, NO2, CN, N3, C1-6 alkyl, C2-6 alkenyl,C2-6 alkynyl, C1-6 alkylamino, di (C1-6 alkyl) amino, C3-6 cycloalkylamino, C3-6 cycloalkyl, halo, C1-6 alkoxy, carboxy, C1-6 alkoxycarbonyl, C1-6 alkylthio, C1 alkylsulfonyl -6, (C1-6 alkyl) 0-2 aminomethyl, or CF3; R10 and R11 each independently is H, OH, SH, NH2, halo, C1-10 alkylcarbonyl, monophosphate, diphosphate, triphosphate, phosphoryl such as phosphate, phosphonate, phosphinate, phosphonoamidate, carbamate, phosphorothioate, phosphorodithioate, carbonyl, thiocarbonyl, aminoacyl , amidine, NO2, CN, N3, sulfonyl, sulfoxide, sulfate, sulfonate, sulfamoyl, sulfonamide, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, acyl, haloalkyl, haloalkenyl, haloalkynyl, cyclopropyl, CONH2,One person or each person or each person or each person or each person or each person or each person - R-R Depending on the appropriate Valencia required, dotted lines indicate the presence of a simple or double-sided link; or a pharmaceutically acceptable salt or salt made, or a stereoscopic / isomerized salt or Taurus form therein.
机译:抑制RNA依赖性病毒RNA复制的核苷类似物化合物,包含这些化合物的组合物以及这些化合物在治疗感染的宿主中的病毒感染,尤其是丙型肝炎中的用途。 1,具有通式(1)的化合物,其中X为O,S,SO 2,N-R,CH-R或C-RR; R是H; C 1-4烷基,C 2-4烯基或C 2-4炔基,它们各自可以被任选取代; CN,N3,卤素,OH,CONH2,NH2或a基; R1是OH,一磷酸酯,二磷酸酯,三磷酸酯,膦酸酯,磷酰基,膦酸酯的衍生物,酰基,氢,烷基,O-酰基,O-烷基,O-芳基,O-alcoxialquilo O-ariloxialquilo O-alquilo取代基O-alquenilo取代基邻氨基丙二酸体内可取代的二倍丙炔基羟基OH体内R2 R3 R4或R5 cada烯基独立的烯丙基卤代卤代碳烯基卤代卤代邻苯二甲酰基卤代卤代1 -烷基磺酰基;邻焦油o-aculo;星; s-alquenilo; s-acilo; NH焦油; n(TAR)2; NH(alquenilo); N(alquenilo)2; NH(TAR); N(沥青)2; NH(ACIO); N(酰基)2; CONH2; COOH; CONH-烷基; CON(烷基)2; COSH2; COSH-烷基; COS(烷基)2; C 1-6 -O-C 1-6烷基; C 1-6 -O-烯基烷基; C1-6-O-炔基烷基; C 1-6 -S-烷基; C 1-6 -S-链烯基烷基; C 1-6 -S-炔基烷基; CH2CN;或CH2N3; R 1',R 2',R3',R4',R5'和W各自独立地为H,OH,C1-10烷基羰基,磷酰基,膦酸酯,次膦酸酯,氨基磷酸酯,Cl,F,Br,I,CN,NO2 N3,NH2,酰基氨基,酰胺,am,C1-6烷基,C2-6烯基,C2-6炔基,羰基,硫代羰基,酰基,卤代烷基,卤代烯基,卤代炔基,环丙基,磺酰基,亚砜,硫酸盐,磺酸盐,氨磺酰基,磺酰胺,C1-6-O-C1-6烷基,C1烷基-6-O-烯基,C1-6-O-炔基烷基,C1-6-S-烷基,C1-6-S-烯基烷基,C1-6 -S-炔基烷基,CONH 2,COOR,CH 2 CN或CH 2 N 3;每个R 2,R 3,R 4和R 5及其相应的R′可形成半螺线;每个R 2 + R 3,R 3 + R 4或R 4 + R 5可以组合成由3-6个成员组成的环,其中可以选择1-3个非原子。每个R 2'+ R 3',R 3'+ R 4',OR 4'+ R 5'可以独立地组合成由3-6个成员组成的环,并且该环可以任选地由1-3个杂原子组成;预期至少两个R2,R3,R4,R5和W应该为oh;进一步预测,只有当x是ch-r或c-r-r时w才是oh;并且R1,R2和R3,R4或R5的任何其他预览是Oh或NH2,然后是R1R2',R3',相应的r4'o R5'不能同时是Oh或NH2;该参考选自(2)组,其特征在于,根据正确的化合价,每次出现的A,L和T独立地为CH,N,C-烷基,O或S。或C-卤代,C-C1-6烷基,C-C2-6烯基,C-C2-6炔基,C2-6烷基氨基,C-CF3,C-OH,C-NH2,C-NO2,C-CN ,C-N3,C-COOR或C-CONH2; D是CH,C-CN,C-NO 2,N,C-C 1-6烷基,C-CONH 2,C-CONH-C 1-6烷基,C-CON(C 1-6烷基)(C 1-6烷基), C-NH2,C-烷氧基,C-OH,C-烷基氨基,CC(= NH)NH2,C-COOH,C-COO-烷基,C-CSNH2,C-CSNH-烷基,C-CSN(烷基)2 C 1 -C 2-(C 1-6烷基)氨基,C-卤代,C-杂环,其中任何烷基任选地被1-3个选自烷氧基,羟基,羧基,卤素和氨基的取代基取代,并且其中杂环是具有1至3个杂原子的5至6元环; E为N或C-卤代,C-C1-6烷基,C-C2-6烯基,C-C2-6炔基,C1-6烷基氨基,C-CF3,C-OH,C-NH2,C-NO2 C-CN,C-N3,C-COOR或C-CONH2; Z为O或S; R 6,R 7,R 8和R 9各自独立地是H,OH,SH,NH 2,NO 2,CN,N 3,C 1-6烷基,C 2-6烯基,C 2-6炔基,C 1-6烷基氨基,二(C 1-6烷基)氨基,C 3-6环烷基氨基,C 3-6环烷基,卤素,C 1-6烷氧基,羧基,C 1-6烷氧基羰基,C 1-6烷硫基,C 1烷基磺酰基-6,(C 1-6烷基)0-2氨基甲基,或CF3; R 10和R 11各自独立地是H,OH,SH,NH 2,卤素,C 1-10烷基羰基,单磷酸酯,二磷酸酯,三磷酸酯,磷酸酯如磷酸酯,膦酸酯,次膦酸酯,膦酰胺酸酯,氨基甲酸酯,硫代磷酸酯,二硫代磷酸酯,羰基,硫代羰基,氨基酰基idine,NO2,CN,N3,磺酰基,亚砜,硫酸盐,磺酸盐,氨磺酰基,磺酰胺,C1-6烷基,C2-6烯基,C2-6炔基,酰基,卤代烷基,卤代烯基,卤代炔基,环丙基,CONH2,一个人或每个人或每个人或每个人或每个人或每个人或每个人-RR根据所需的适当的瓦伦西亚,虚线表示存在简单或双面链接;或制成的药学上可接受的盐或盐,或其中形成立体/异构化的盐或金牛座。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号